Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
Abroad (travel likely)Active Not RecruitingPHASE1
Conditions
Food Allergy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of South Florida, Tampa, Florida, United States
Emory University - Winship Cancer Institute, Atlanta, Georgia, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals
View source on ClinicalTrials.gov(opens in a new tab)
No study contact email or phone is listed for this trial.